Forxiga: Clinical Trials

7 trials of Forxiga, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 unknown. 7 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 17Completed 5, Terminated 1, Unknown 1

Follow Forxiga: new trials by email Literature Review of Forxiga trials Research Report on Forxiga

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)
Dapagliflozin, Placebo oral tablet, Stress - Type 1 Diabetes, Diabetic Ketoacidosis
Phase 1TerminatedKinderkrankenhaus auf der Bult22022-05-182024-12-09
Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects
Forxiga, DA-2811 - Healthy
Phase 1CompletedDong-A ST Co., Ltd.602020-08-042021-03-05
Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults
Evogliptin→Evogliptin+Empagliflozin→Empagliflozin, Empagliflozin→Evogliptin→Evogliptin+Empagliflozin, Evogliptin→Evogliptin+Dapagliflozin→Dapagliflozin - Type2 Diabetes
Phase 1CompletedDong-A ST Co., Ltd.422018-11-222019-04-10
Gemigliptin, Dapagliflozin, Empagliflozin DDI Study
Gemigliptin, Dapagliflozin, Empagliflozin - Type 2 Diabetes Mellitus
Phase 1UnknownLG Chem482018-04-052018-06-21
Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes
Dapagliflozin, Placebo Oral Tablet - Type1diabetes
Phase 1CompletedKinderkrankenhaus auf der Bult302017-02-092024-10-15
Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes
dapagliflozin, Placebo - Type 1 Diabetes
Phase 1CompletedKinderkrankenhaus auf der Bult362014-12-012016-02-19
A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy Volunteers
Canagliflozin, Dapagliflozin - Healthy
Phase 1CompletedJanssen-Cilag International NV602013-07-012014-03-26

Conditions studied

Diabetes Mellitus, Type 1 (2)  ·  Diabetes Mellitus, Type 2 (1)  ·  Diabetic Ketoacidosis (1)

Sponsors

Kinderkrankenhaus auf der Bult (3)  ·  Dong-A ST Co., Ltd. (2)  ·  Janssen-Cilag International NV (1)  ·  LG Chem (1)

Countries

Germany (4)  ·  South Korea (3)

Top investigators

Thomas Danne, MD (2)  ·  JaeYong Chung (1)  ·  Torben Biester, MD (1)